<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font26 { font-size : 26; } .font29 { font-size : 29; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">patients </span>
   <span class="font30">[]. </span>
   <span class="font29">COVID- </span>
   <span class="font26">clinical </span>
   <span class="font22">CRS </span>
   <span class="font21">cells </span>
   <span class="font21">IL- </span>
   <span class="font19">severe </span>
   <span class="font19">cell </span>
   <span class="font18">treatment </span>
   <span class="font18">immune </span>
   <span class="font18">respiratory </span>
   <span class="font17">{border-style </span>
   <span class="font17">cytokine </span>
   <span class="font17">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">therapy </span>
   <span class="font15">(â€") </span>
   <span class="font15">including </span>
   <span class="font15">syndrome </span>
   <span class="font15">tocilizumab </span>
   <span class="font15">associated </span>
   <span class="font15">inflammatory </span>
   <span class="font15">use </span>
   <span class="font14">Med </span>
   <span class="font14">currently </span>
   <span class="font14">virus </span>
   <span class="font14">/â€" </span>
   <span class="font14">acute </span>
   <span class="font14">described </span>
   <span class="font14">disease </span>
   <span class="font13">IRIS </span>
   <span class="font13">[], </span>
   <span class="font13">administration </span>
   <span class="font13">days </span>
   <span class="font13">infection </span>
   <span class="font13">receptor </span>
   <span class="font13">therapies </span>
   <span class="font13">trials </span>
   <span class="font13">viral </span>
   <span class="font13">(.â€".) </span>
   <span class="font13">(â€".) </span>
   <span class="font13">Cell </span>
   <span class="font13">Engl </span>
   <span class="font13">Table </span>
   <span class="font13">cellular </span>
   <span class="font13">data </span>
   <span class="font13">phase </span>
   <span class="font13">potential </span>
   <span class="font13">safety </span>
   <span class="font13">study </span>
   <span class="font13">COVID-. </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">Society </span>
   <span class="font13">allogeneic </span>
   <span class="font13">antiviral </span>
   <span class="font13">coronavirus </span>
   <span class="font13">high </span>
   <span class="font13">hospitalized </span>
   <span class="font13">human </span>
   <span class="font13">hyperimmune </span>
   <span class="font13">information </span>
   <span class="font13">levels </span>
   <span class="font13">lung </span>
   <span class="font13">novel </span>
   <span class="font13">px; </span>
   <span class="font13">related </span>
   <span class="font13">studies </span>
   <span class="font13">therapeutic </span>
   <span class="font13">{font-family </span>
   <span class="font12">HLH </span>
   <span class="font12">However, </span>
   <span class="font12">MSC </span>
   <span class="font12">MSCs </span>
   <span class="font12">activity </span>
   <span class="font12">approved </span>
   <span class="font12">cells, </span>
   <span class="font12">conditions </span>
   <span class="font12">dose </span>
   <span class="font12">efficacy </span>
   <span class="font12">features </span>
   <span class="font12">font-size </span>
   <span class="font12">plasma </span>
   <span class="font12">release </span>
   <span class="font12">research </span>
   <span class="font12">response </span>
   <span class="font12">responses </span>
   <span class="font12">sHLH </span>
   <span class="font12">and/or </span>
   <span class="font12">day </span>
   <span class="font12">double; </span>
   <span class="font12">drugs </span>
   <span class="font12">hematopoietic </span>
   <span class="font12">hosts </span>
   <span class="font12">mortality </span>
   <span class="font12">provide </span>
   <span class="font12">severity </span>
   <span class="font12">stem </span>
   <span class="font12">trial </span>
   <span class="font12">used </span>
   <span class="font12">vitro </span>
   <span class="font11">(nÂ </span>
   <span class="font11">April </span>
   <span class="font11">CAR-T </span>
   <span class="font11">Elsevier </span>
   <span class="font11">Gene </span>
   <span class="font11">Grade </span>
   <span class="font11">Requiring </span>
   <span class="font11">T-cell </span>
   <span class="font11">Temperature </span>
   <span class="font11">Therapy </span>
   <span class="font11">[published </span>
   <span class="font11">activation </span>
   <span class="font11">adverse </span>
   <span class="font11">ahead </span>
   <span class="font11">antibody </span>
   <span class="font11">blood </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cells. </span>
   <span class="font11">combination </span>
   <span class="font11">convalescent </span>
   <span class="font11">criteria </span>
   <span class="font11">elevated </span>
   <span class="font11">evaluation </span>
   <span class="font11">given </span>
   <span class="font11">higher </span>
   <span class="font11">hyperinflammatory </span>
   <span class="font11">important </span>
   <span class="font11">increase </span>
   <span class="font11">infected </span>
   <span class="font11">limited </span>
   <span class="font11">nasal </span>
   <span class="font11">observed </span>
   <span class="font11">online </span>
   <span class="font11">pandemic </span>
   <span class="font11">patient </span>
   <span class="font11">range </span>
   <span class="font11">recently </span>
   <span class="font11">role </span>
   <span class="font11">serum </span>
   <span class="font11">solid; </span>
   <span class="font11">specific </span>
   <span class="font11">syndromes </span>
   <span class="font11">treatments </span>
   <span class="font11">vesicles </span>
   <span class="font11">virus, </span>
   <span class="font11">virus-specific </span>
   <span class="font11">viruses </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">â‰¥Â°C </span>
   <span class="font11">â€" </span>
   <span class="font11">Clinical </span>
   <span class="font11">Currently, </span>
   <span class="font11">IL-, </span>
   <span class="font11">IRIS. </span>
   <span class="font11">Immunol </span>
   <span class="font11">International </span>
   <span class="font11">MERS </span>
   <span class="font11">Moreover, </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">Tocilizumab </span>
   <span class="font11">[,]. </span>
   <span class="font11">adult </span>
   <span class="font11">adults </span>
   <span class="font11">anakinra </span>
   <span class="font11">available </span>
   <span class="font11">based </span>
   <span class="font11">bold </span>
   <span class="font11">bone </span>
   <span class="font11">care </span>
   <span class="font11">centre </span>
   <span class="font11">cohort </span>
   <span class="font11">common </span>
   <span class="font11">courier; </span>
   <span class="font11">critically </span>
   <span class="font11">current </span>
   <span class="font11">dampen </span>
   <span class="font11">develop </span>
   <span class="font11">distress </span>
   <span class="font11">em; </span>
   <span class="font11">evaluating </span>
   <span class="font11">events </span>
   <span class="font11">failure </span>
   <span class="font11">grading </span>
   <span class="font11">increased </span>
   <span class="font11">influenza </span>
   <span class="font11">inhibitors </span>
   <span class="font11">laboratory </span>
   <span class="font11">likely </span>
   <span class="font11">mild </span>
   <span class="font11">moderate </span>
   <span class="font11">monoclonal </span>
   <span class="font11">multiple </span>
   <span class="font11">oxygen </span>
   <span class="font11">pathogenesis </span>
   <span class="font11">patients, </span>
   <span class="font11">patients. </span>
   <span class="font11">placebo </span>
   <span class="font11">potentially </span>
   <span class="font11">present </span>
   <span class="font11">print </span>
   <span class="font11">pt;} </span>
   <span class="font11">public </span>
   <span class="font11">randomized </span>
   <span class="font11">reconstitution </span>
   <span class="font11">remains </span>
   <span class="font11">requiring </span>
   <span class="font11">resource </span>
   <span class="font11">responsible </span>
   <span class="font11">rheumatoid </span>
   <span class="font11">signaling </span>
   <span class="font11">soluble </span>
   <span class="font11">storm </span>
   <span class="font11">support </span>
   <span class="font11">supportive </span>
   <span class="font11">therefore, </span>
   <span class="font11">time </span>
   <span class="font11">tissue </span>
   <span class="font11">treated </span>
   <span class="font11">type </span>
  </p>
 </body>
</html>
